Nigel McArdle1,2, Amy C Reynolds3, David Hillman1,2, Eric Moses4,5, Kath Maddison1,2, Phillip Melton4,6, Peter Eastwood3. 1. University of Western Australia, School of Health Sciences, Nedlands, Western Australia, Australia. 2. West Australian Sleep Disorders Research Institute, Nedlands, Western Australia, Australia. 3. Flinders Health and Medical Research Institute (Sleep Health), College of Medicine and Public Health, Flinders University, South Australia, Australia. 4. Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia. 5. School of Biological Sciences, University of Western Australia, Crawley, Western Australia, Australia. 6. School of Global and Population Health, University of Western Australia, Nedlands, Western Australia, Australia.
Abstract
STUDY OBJECTIVES: There is a paucity of contemporary prevalence estimates for common sleep disorders of insomnia, obstructive sleep apnea (OSA), and restless legs syndrome. We aimed to assess the prevalence of clinically significant common sleep disorders in a middle-aged community sample. METHODS: Parents of participants in the community-based Raine Study underwent assessments between 2015 and 2017, including comprehensive questionnaires, anthropometric measures, and in-laboratory polysomnography. Clinically significant sleep disorders were defined as chronic insomnia using the Pittsburgh Sleep Symptom Questionnaire-Insomnia with duration criterion ≥ 3 months; OSA as apnea-hypopnea index ≥ 5 events/h with excessive sleepiness (Epworth Sleepiness Scale ≥ 11) or apnea-hypopnea index ≥ 15 events/h (even in the absence of symptoms); restless legs syndrome when participants endorsed the International Restless Legs Syndrome Study Group diagnostic criteria (2003) with symptoms ≥ 5 times/month involving moderate-severe distress. RESULTS: At least 1 sleep-related assessment was completed by 1,005 (female = 586, 58.3%) middle-aged (45-65 years) participants, 72.5% of eligible Raine Study parents. The respective prevalences for clinically significant disease in females and males were as follows: OSA, 24.0% (95% confidence interval [CI]: 20.5-27.7) and 47.3% (95% CI: 42.2-53.4); insomnia, 15.8% (95% CI: 13.1-19.0) and 9.3% (95% CI: 6.8-12.4); restless legs syndrome, 3.7% (95% CI: 2.4-5.4) and 2.2% (95% CI: 1.1-3.9). At least 1 sleep disorder was present in 42.9% of those with complete data on all assessments (n = 895). CONCLUSIONS: Common sleep disorders are highly prevalent, to a clinically important extent, in an Australian community sample of middle-aged adults. Contemporary OSA prevalence is notably higher than previously reported and further work is needed to determine the communal impact of OSA. CITATION: McArdle N, Reynolds AC, Hillman D, et al. Prevalence of common sleep disorders in a middle-aged community sample. J Clin Sleep Med. 2022;18(6):1503-1514.
STUDY OBJECTIVES: There is a paucity of contemporary prevalence estimates for common sleep disorders of insomnia, obstructive sleep apnea (OSA), and restless legs syndrome. We aimed to assess the prevalence of clinically significant common sleep disorders in a middle-aged community sample. METHODS: Parents of participants in the community-based Raine Study underwent assessments between 2015 and 2017, including comprehensive questionnaires, anthropometric measures, and in-laboratory polysomnography. Clinically significant sleep disorders were defined as chronic insomnia using the Pittsburgh Sleep Symptom Questionnaire-Insomnia with duration criterion ≥ 3 months; OSA as apnea-hypopnea index ≥ 5 events/h with excessive sleepiness (Epworth Sleepiness Scale ≥ 11) or apnea-hypopnea index ≥ 15 events/h (even in the absence of symptoms); restless legs syndrome when participants endorsed the International Restless Legs Syndrome Study Group diagnostic criteria (2003) with symptoms ≥ 5 times/month involving moderate-severe distress. RESULTS: At least 1 sleep-related assessment was completed by 1,005 (female = 586, 58.3%) middle-aged (45-65 years) participants, 72.5% of eligible Raine Study parents. The respective prevalences for clinically significant disease in females and males were as follows: OSA, 24.0% (95% confidence interval [CI]: 20.5-27.7) and 47.3% (95% CI: 42.2-53.4); insomnia, 15.8% (95% CI: 13.1-19.0) and 9.3% (95% CI: 6.8-12.4); restless legs syndrome, 3.7% (95% CI: 2.4-5.4) and 2.2% (95% CI: 1.1-3.9). At least 1 sleep disorder was present in 42.9% of those with complete data on all assessments (n = 895). CONCLUSIONS: Common sleep disorders are highly prevalent, to a clinically important extent, in an Australian community sample of middle-aged adults. Contemporary OSA prevalence is notably higher than previously reported and further work is needed to determine the communal impact of OSA. CITATION: McArdle N, Reynolds AC, Hillman D, et al. Prevalence of common sleep disorders in a middle-aged community sample. J Clin Sleep Med. 2022;18(6):1503-1514.
Authors: Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee Journal: Sleep Med Date: 2014-05-17 Impact factor: 3.492
Authors: Maria Didriksen; Andreas S Rigas; Richard P Allen; Brendan J Burchell; Emanuele Di Angelantonio; Maria H Nielsen; Poul Jennum; Thomas Werge; Christian Erikstrup; Ole B Pedersen; Mie T Bruun; Kristoffer S Burgdorf; Erik Sørensen; Henrik Ullum Journal: Sleep Med Date: 2017-05-26 Impact factor: 3.492
Authors: Nigel McArdle; Sarah V Ward; Romola S Bucks; Kathleen Maddison; Anne Smith; Rae-Chi Huang; Craig E Pennell; David R Hillman; Peter R Eastwood Journal: Sleep Date: 2020-10-13 Impact factor: 5.849
Authors: Erla Björnsdóttir; Christer Janson; Jón F Sigurdsson; Philip Gehrman; Michael Perlis; Sigurdur Juliusson; Erna S Arnardottir; Samuel T Kuna; Allan I Pack; Thorarinn Gislason; Bryndis Benediktsdóttir Journal: Sleep Date: 2013-12-01 Impact factor: 5.849
Authors: Amy C Reynolds; Bastien Lechat; Yohannes Adama Melaku; Kelly Sansom; Brandon W J Brown; Meagan E Crowther; Sian Wanstall; Kathleen J Maddison; Jennifer H Walsh; Leon Straker; Robert J T Adams; Nigel McArdle; Peter R Eastwood Journal: Sci Rep Date: 2022-09-28 Impact factor: 4.996